What is the appropriate management of hypernatremia in a patient with acute kidney injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypernatremia in Acute Kidney Injury

In patients with AKI and hypernatremia, use continuous renal replacement therapy (CRRT) with customized replacement fluid to achieve slow, controlled correction of serum sodium at a rate not exceeding 8-10 mEq/L per 24 hours, avoiding rapid correction that can precipitate dialysis disequilibrium syndrome.

Core Management Principles

The fundamental challenge in managing hypernatremia with concurrent AKI is that standard dialysis solutions contain fixed sodium concentrations (typically 140 mEq/L), which can cause dangerously rapid correction when serum sodium is severely elevated. CRRT offers the critical advantage of allowing customized sodium concentrations in replacement fluids to prevent overly rapid correction 1, 2.

Why CRRT is Preferred

  • Controlled correction rate: CRRT allows gradual sodium normalization, preventing dialysis disequilibrium syndrome that occurs with rapid correction in hypernatremic patients 1
  • Customizable replacement fluid: Commercial solutions can be modified to match the patient's current sodium level, then gradually adjusted downward 2
  • Hemodynamic stability: Particularly important in AKI patients who are often hemodynamically unstable 3

Practical Implementation Algorithm

Step 1: Assess Severity and Identify Contributing Factors

Look specifically for:

  • Inability to access free water (80% of severe hypernatremia patients are intubated and cannot drink) 4
  • Ongoing free water losses: Fever (present in 25% of cases), diuretic use (34% of cases), high urine output 4
  • Inadequate free water replacement: 50% of patients with severe hypernatremia receive no hypotonic fluids 4
  • Urinary electrolyte losses: Measure urine sodium and calculate electrolyte-free water clearance (though only done in 7% of cases in practice) 4

Step 2: Choose RRT Modality

Select CRRT over intermittent hemodialysis for the following reasons 3:

  • Hemodynamically unstable patients (most AKI patients requiring RRT)
  • Need for precise sodium control
  • Severe hypernatremia (≥155 mmol/L)
  • Concurrent fluid overload requiring careful fluid removal

The 2020 KDIGO guidelines emphasize that modality selection should be tailored to clinical status, with continuous RRT being more physiologically appropriate in unstable patients 3.

Step 3: Customize Replacement Fluid

Calculate target sodium concentration for replacement fluid 2:

  • Start with replacement fluid sodium concentration close to patient's current serum sodium
  • Use formulas to adjust commercial solutions (typically 140 mEq/L) by adding hypertonic saline or diluting with dextrose solutions
  • Plan gradual reduction in replacement fluid sodium concentration

Step 4: Set Correction Rate

Target correction rate: 8-10 mEq/L per 24 hours maximum 1

  • Slower rates (0.3-0.5 mEq/L per hour) are safer
  • Monitor serum sodium every 2-4 hours initially
  • Adjust replacement fluid sodium concentration as serum sodium decreases

Real-world data shows actual correction rates average -2.8 mmol/L per day in the first 3 days after peak hypernatremia 4, which is appropriately conservative.

Step 5: Address Underlying Causes Simultaneously

While initiating CRRT:

  • Stop or reduce diuretics if possible (used in 34% of hypernatremic patients) 4
  • Treat fever aggressively (present in 25% of cases) 4
  • Provide enteral free water if gut function permits and patient can tolerate
  • Avoid hypertonic saline and sodium-containing medications

Step 6: Fluid Management During CRRT

The 2020 KDIGO guidelines emphasize achieving goals of electrolyte, acid-base, solute, and fluid balance 3:

  • Effluent volume: 20-25 mL/kg/h for continuous RRT 3
  • Fluid removal rate: Controversial and requires individualization, but avoid aggressive ultrafiltration that concentrates sodium further
  • Monitor fluid balance: Methods to better assess fluid management goals remain an area needing research 3

Critical Pitfalls to Avoid

  1. Using standard dialysate without customization: This causes overly rapid correction and risks dialysis disequilibrium syndrome 1

  2. Failing to measure urinary losses: Only 7% of patients have urine sodium measured, yet this is critical for calculating free water deficits 4

  3. Continuing diuretics: One-third of hypernatremic patients remain on diuretics, exacerbating free water losses 4

  4. Inadequate monitoring: Check serum sodium every 2-4 hours during active correction phase

  5. Correcting too rapidly: Even with CRRT, overly aggressive ultrafiltration or inappropriate replacement fluid composition can cause rapid shifts

Special Considerations in AKI

  • Impaired renal concentrating ability: AKI patients often have high urine output with inappropriate free water losses (median electrolyte-free water clearance of -1.1 L, representing half of urine output) 4

  • Concurrent fluid overload: Many AKI patients have both hypernatremia and volume overload, requiring careful balance between sodium correction and fluid removal 5

  • Hemodynamic instability: Continuous RRT is preferred over intermittent hemodialysis as it causes less intracranial pressure changes and is better tolerated 3

Monitoring and Endpoints

  • Serum sodium: Every 2-4 hours initially, then every 6-8 hours once stable correction achieved
  • Neurological status: Watch for signs of dialysis disequilibrium (confusion, seizures, altered mental status)
  • Fluid balance: Track inputs/outputs meticulously
  • Urine electrolytes: If patient still producing urine, measure sodium and calculate free water clearance

Discontinue CRRT when: Serum sodium normalizes (135-145 mEq/L), kidney function recovers sufficiently to manage sodium balance, or when RRT becomes inconsistent with goals of care 3.

Related Questions

In an 85-year-old female with impaired renal function (creatinine 1.77 mg/dL, BUN 20.5 mg/dL, GFR 28 mL/min), hypernatremia (serum sodium 153 mmol/L), normokalemia (potassium 3.7 mmol/L), who is drowsy and has decreased appetite, which intravenous fluid should be administered?
What are the causes of hypernatremia in the Intensive Care Unit (ICU)?
How does Continuous Renal Replacement Therapy (CRRT) facilitate nutritional therapy delivery?
How many milliliters equivalent per hour of sodium am I removing in an 80 kg patient undergoing Continuous Renal Replacement Therapy (CRRT) with a fluid dose of 1000 mL per hour?
Should hypernatremia correction with D5W (Dextrose 5% in Water) in a postoperative patient with acute kidney injury (AKI) on chronic kidney disease (CKD) be done slowly over 48 hours?
In an 80‑year‑old male who underwent repair of a hip fracture and is now confused, repeatedly calling for his relative, is afebrile, compliant, receiving oxycodone and corrective insulin, and is not physically aggressive, what is the most appropriate next step in management?
How is exposure and response prevention (ERP) effective for obsessive‑compulsive disorder (OCD)?
Can I stop escitalopram (Lexapro) 20 mg and start sertraline (Zoloft) 50 mg immediately?
A 70‑year‑old man with prior percutaneous coronary intervention, diabetes mellitus, and hypertension presents with exertional midsternal chest pain not relieved by rest, radiating to the neck and jaw, 2 mm ST‑segment depression and T‑wave changes in leads V1‑V2, and normal initial troponin; what is the most likely diagnosis (gastroesophageal reflux disease, unstable angina pectoris, stable angina pectoris, or non‑ST‑elevation myocardial infarction)?
What is the increased risk of hepatitis C virus infection in individuals with tattoos, especially when the tattoo was obtained in non‑sterile or unregulated settings?
What is the recommended treatment approach for normal‑tension glaucoma in an adult over 40 with intra‑ocular pressure already within the normal range?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.